Trabectedin for the treatment of advanced soft tissue sarcoma

National Institute for Health and Clinical Excellence
Record ID 32011000080
English
Authors' recomendations: Trabectedin is recommended as a treatment option for people with advanced soft tissue sarcoma if: treatment with anthracyclines and ifosfamide has failed or they are intolerant of or have contraindications for treatment with anthracyclines and ifosfamide and the acquisition cost of trabectedin for treatment needed after the fifth cycle is met by the manufacturer.
Details
Project Status: Completed
Year Published: 2010
URL for published report: http://www.nice.org.uk/TA185
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Antineoplastic Agents, Alkylating
  • Sarcoma
  • Tetrahydroisoquinolines
Contact
Organisation Name: National Institute for Health and Care Excellence
Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name: nice@nice.nhs.uk
Contact Email: nice@nice.nhs.uk
Copyright: National Institute for Health and Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.